Search research articles
Contact Us
Filters
Showing results (511-520 of 548) with videos related to
Page
of 55
Sort By:
Genome Research
|
May 15, 2025
A new compression strategy to reduce the size of nanopore sequencing data
Kavindu Jayasooriya, Sasha P Jenner, Pasindu Marasinghe, et al.
Annals of Neurology
|
September 1, 1994
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
J Sian, D T Dexter, A J Lees, et al.
The European Journal of Neuroscience
|
February 28, 2002
Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets
I Lastres-Becker, M Cebeira, M L de Ceballos, et al.
Neuroreport
|
May 30, 1995
Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
K S McNaught, C Altomare, S Cellamare, et al.
British Journal of Pharmacology
|
January 1, 1995
Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitro indazole
M T Silva, S Rose, J G Hindmarsh, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration
|
September 1, 1996
Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
K S McNaught, U Thull, P A Carrupt, et al.
Journal of Neurochemistry
|
February 1, 1989
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
D T Dexter, C J Carter, F R Wells, et al.
Biochemical Pharmacology
|
July 12, 1996
Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
K S McNaught, U Thull, P A Carrupt, et al.
Biochemical Pharmacology
|
November 27, 1995
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
K S McNaught, U Thull, P A Carrupt, et al.
Journal of Neurochemistry
|
November 1, 1986
Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset
P Jenner, H Taquet, A Mauborgne, et al.
Page
of 55
Search research articles
Search
Showing results (511-520 of 548) with videos related to
Sort By:
Page
of 55
Genome Research
|
May 15, 2025
A new compression strategy to reduce the size of nanopore sequencing data
Kavindu Jayasooriya, Sasha P Jenner, Pasindu Marasinghe, et al.
Annals of Neurology
|
September 1, 1994
Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia
J Sian, D T Dexter, A J Lees, et al.
The European Journal of Neuroscience
|
February 28, 2002
Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets
I Lastres-Becker, M Cebeira, M L de Ceballos, et al.
Neuroreport
|
May 30, 1995
Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
K S McNaught, C Altomare, S Cellamare, et al.
British Journal of Pharmacology
|
January 1, 1995
Increased striatal dopamine efflux in vivo following inhibition of cerebral nitric oxide synthase by the novel monosodium salt of 7-nitro indazole
M T Silva, S Rose, J G Hindmarsh, et al.
Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration
|
September 1, 1996
Nigral cell loss produced by infusion of isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
K S McNaught, U Thull, P A Carrupt, et al.
Journal of Neurochemistry
|
February 1, 1989
Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease
D T Dexter, C J Carter, F R Wells, et al.
Biochemical Pharmacology
|
July 12, 1996
Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
K S McNaught, U Thull, P A Carrupt, et al.
Biochemical Pharmacology
|
November 27, 1995
Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
K S McNaught, U Thull, P A Carrupt, et al.
Journal of Neurochemistry
|
November 1, 1986
Lack of change in basal ganglia neuropeptide content following subacute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of the common marmoset
P Jenner, H Taquet, A Mauborgne, et al.
Page
of 55